N-monosubstituted thiosemicarbazide as novel Ure inhibitors: synthesis, biological evaluation and molecular docking

被引:21
作者
Ni, Wei-Wei [1 ]
Fang, Hai-Lian [1 ]
Ye, Ya-Xi [2 ]
Li, Wei-Yi [1 ]
Yuan, Chu-Ping [1 ]
Li, Dong-Dong [3 ]
Mao, Shi-Jia [1 ]
Li, Su-E [1 ]
Zhu, Qi-Hui [1 ]
Ouyang, Hui [1 ]
Xiao, Zhu-Ping [1 ,2 ]
Zhu, Hai-Liang [1 ,2 ]
机构
[1] Jishou Univ, Natl Demonstrat Ctr Expt Chem Educ, Hunan Engn Lab Anal & Drugs Dev Ethnomed Wuling M, Jishou 416000, Peoples R China
[2] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
[3] Nanjing Forestry Univ, Coll Chem Engn, 159 Long Pan Rd, Nanjing 210037, Peoples R China
基金
中国国家自然科学基金;
关键词
Helicobacter pylori; molecular docking; N-monosubstituted thiosemicarbazides; surface plasmon resonance; Ure inhibitor; CRYSTAL-STRUCTURE; IN-VITRO; DERIVATIVES; KINETICS;
D O I
10.4155/fmc-2020-0048
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Identification of novel Ure inhibitors with high potency has received considerable attention. Methodology/results: Ure inhibition was determined using the indophenol method, the affinities to Ure were estimated via surface plasmon resonance. Seventeen new plus ten known N-monosubstituted thiosemicarbazides were synthesized and identified as novel Ure inhibitors. Out of these compounds, compound b5 shows excellent activity against both crude Ure from Helicobacter pylori (IC50 = 0.04 mu M) and Ure in living cell (IC50 = 0.27 mu M), with the potency being over 600-fold higher than clinical used drug acetohyroxamic acid, respectively. Surface plasmon resonance demonstrated the high affinity (K-d = 6.32 nM) of b5 to Ure. Conclusion: This work provides a class of novel and promising Ure inhibitors.
引用
收藏
页码:1633 / 1645
页数:13
相关论文
共 28 条
[1]   Synthetic nicotinic/isonicotinic thiosemicarbazides: In vitro urease inhibitory activities and molecular docking studies [J].
Ali, Basharat ;
Khan, Khalid Mohammed ;
Arshia ;
Kanwal ;
Hussain, Shafqat ;
Hussain, Safdar ;
Ashraf, Muhammad ;
Riaz, Muhammad ;
Wadood, Abdul ;
Perveen, Shahnaz .
BIOORGANIC CHEMISTRY, 2018, 79 :34-45
[2]  
[Anonymous], 2015, SYBYL MOL MOD SOFTW
[3]   Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors [J].
Aslam, Muhammad Adil S. ;
Mahmood, Shams-ul ;
Shahid, Mohammad ;
Saeed, Aamer ;
Iqbal, Jamshed .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) :5473-5479
[4]   Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones [J].
Bondzic, Bojan P. ;
Dzambaski, Zdravko ;
Kolarevic, Ana ;
Dordevic, Aleksandra ;
Anderluh, Marko ;
Smelcerovic, Andrija .
FUTURE MEDICINAL CHEMISTRY, 2019, 11 (18) :2415-2426
[5]   Synthesis, enzyme inhibitory kinetics, and computational studies of novel 1-(2-(4-isobutylphenyl) propanoyl)-3-arylthioureas as Jack bean urease inhibitors [J].
Fattah, Tanzeela Abdul ;
Saeed, Aamer ;
Channar, Pervaiz Ali ;
Ashraf, Zaman ;
Abbas, Qamar ;
Hassan, Mubashir ;
Larik, Fayaz Ali .
CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 91 (02) :434-447
[6]   Ureases as a target for the treatment of gastric and urinary infections [J].
Follmer, C. .
JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (05) :424-430
[7]   Transcriptional regulators: valuable targets for novel antibacterial strategies [J].
Gonzalez, Andres ;
Fillat, Maria F. ;
Lanas, Angel .
FUTURE MEDICINAL CHEMISTRY, 2018, 10 (05) :541-560
[8]  
Jeffrey G.A., 2003, CRYSTALLOGR REV, V9, P135, DOI [10.1080/08893110310001621754, DOI 10.1080/08893110310001621754]
[9]   Examining barbiturate scaffold for the synthesis of new agents with biological interest [J].
Katsamakas, Sotirios ;
Papadopoulos, Anastasios G. ;
Kouskoura, Maria G. ;
Markopoulou, Catherine K. ;
Hadjipavlou-Litina, Dimitra .
FUTURE MEDICINAL CHEMISTRY, 2019, 11 (16) :2063-2079
[10]   N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation [J].
Li, Wei-Yi ;
Ni, Wei-Wei ;
Ye, Ya-Xi ;
Fang, Hai-Lian ;
Pan, Xing-Ming ;
He, Jie-Ling ;
Zhou, Tian-Li ;
Yi, Juan ;
Liu, Shan-Shan ;
Zhou, Mi ;
Xiao, Zhu-Ping ;
Zhu, Hai-Liang .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) :404-413